| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/23/1994 | EP0583244A1 Method of producing zero-order controlled-release devices. |
| 02/22/1994 | US5288750 Antiulcer agents for gastrointestinal disorders |
| 02/22/1994 | US5288730 Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy |
| 02/22/1994 | US5288703 Administering syngeristic mixture of animal growth regulator and glutamine |
| 02/22/1994 | US5288507 Administering lysine salt of ibuprofen; enantiomorphs with aluminum and magnesium hydroxide |
| 02/22/1994 | US5288506 Antacid compositions with prolonged gastric residence time |
| 02/22/1994 | CA1327200C Urea derivatives |
| 02/18/1994 | CA2104042A1 Method of treating immunoinflammatory disease |
| 02/18/1994 | CA2103511A1 Gastroprotective complexes |
| 02/17/1994 | WO1994003450A1 Furylthiazole and their use as h2-receptor antagonists and antimicrobial agents |
| 02/17/1994 | WO1994003447A1 Benzodiazepine derivatives |
| 02/17/1994 | WO1994003437A1 Benzodiazepine derivatives |
| 02/17/1994 | WO1994003205A1 Hla binding peptides and their uses |
| 02/17/1994 | WO1994003203A1 Alimentary canal cell activator |
| 02/17/1994 | WO1994003188A1 Ibuprofen-antacid combinations |
| 02/17/1994 | WO1994003187A1 Sugar-free dry mix cellulose ether compositions as bulk laxatives |
| 02/17/1994 | WO1994003181A1 Pharmaceutical compositions and use of dilinoleoylphosphatidylcholine (dlpc) for treatment and prevention of cirrhosis and fibrosis in the liver |
| 02/17/1994 | WO1994003174A1 Treatment of dentoalveolar infections with taurolidine and/or taurultam |
| 02/17/1994 | WO1994003158A1 Solid pharmaceutical dosage forms having an extended two-stage release profile and production thereof |
| 02/17/1994 | CA2141960A1 Hla binding peptides and their uses |
| 02/17/1994 | CA2141432A1 Pharmaceutical compositions and use of dilinoleoylphosphatidylcholine (dlpc) for treatment and prevention of cirrhosis and fibrosis in the liver |
| 02/17/1994 | CA2140917A1 Ibuprofen-antacid combinations |
| 02/17/1994 | CA2140009A1 Benzodiazepine derivatives |
| 02/17/1994 | CA2140008A1 Benzodiazepine derivatives |
| 02/16/1994 | EP0582916A1 N-methansulfonyl-2-(3-isobutyl-3-(quinol-2-yl-methoxy)-phenyl)-2-cycloalkylacetamides, process for their preparation and their pharmaceutical use |
| 02/16/1994 | EP0582631A1 S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof |
| 02/16/1994 | EP0508995B1 Muscarinic receptor antagonists |
| 02/16/1994 | EP0409931B1 Quinuclidine therapeutic agents |
| 02/16/1994 | CN1082046A 9-Amino-pyridazino |4',5':3,4¨ pyrrolo-|2,1-1¨ isochinoline and its application in preparation of pharmaceutic |
| 02/16/1994 | CN1082044A 吲哚衍生物 Indole derivatives |
| 02/15/1994 | US5286731 Method of treating immunoinflammatory bowel disease |
| 02/15/1994 | US5286730 Administering rapamycins for skin disorders |
| 02/15/1994 | US5286718 Administering monophosphoryl lipid A or its 3-deacylated derivative |
| 02/15/1994 | CA1326994C Proteinase inhibitors for treatment of gastrointestinal ulcer disease |
| 02/13/1994 | CA2103600A1 Isobutyl-substituted methanesulphonyl- quinolyl-methoxyphenyl-cycloalkylacetamides |
| 02/09/1994 | EP0582368A1 Thienobenzodiazepine derivatives for treatment of CNS disorders |
| 02/09/1994 | EP0582186A1 Process for producing solid pharmaceutical dosage forms with an extended two-stage release |
| 02/09/1994 | EP0581967A1 Protein with novel pharmacological characteristic |
| 02/09/1994 | CN1081614A Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic |
| 02/08/1994 | US5284957 Substituted 1H- or 2H-tetrazoles |
| 02/08/1994 | US5284868 Naphthopyran derivatives; for autoimmune diseases, cancer |
| 02/08/1994 | US5284839 Neuropeptide antagonist; renal and cerebral areas included |
| 02/08/1994 | US5284835 Use of dilinoleoylphosphatidylcholine (DLPC) for treatment and prevention of cirrhosis and fibrosis in the liver |
| 02/05/1994 | CA2092218A1 Process for the preparation of glycine-conjugated bile acids and relative pharmaceutical compositions useful for treating hepatic insufficiency |
| 02/03/1994 | WO1994002601A1 Non-native liver generation in an animal with impaired native liver function by cell implantation |
| 02/03/1994 | WO1994002511A1 Calcium channel blocking polypeptide from agelenopsis aperta |
| 02/03/1994 | WO1994002493A1 Phosphonated arylethanolamine compounds with anti-hyperglycemic and/or anti-obesity activity |
| 02/03/1994 | WO1994002482A1 1-azaadamantane derivatives as 5-ht agonists or antagonists |
| 02/03/1994 | WO1994002465A1 INHIBITORS OF c-AMP PHOSPHODIESTERASE AND TNF |
| 02/03/1994 | WO1994002447A1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 02/03/1994 | WO1994002446A1 Natural amino acid derivatives as metalloproteinase inhibitors |
| 02/03/1994 | WO1994002141A1 Injection and injection kit containing omeprazole and its analogs |
| 02/03/1994 | WO1994002035A1 Food products containing benzimidazole |
| 02/03/1994 | CA2140785A1 Non-native liver generation in an animal with impaired native liver function by cell implantation |
| 02/03/1994 | CA2140258A1 Food products containing benzimidazole |
| 02/03/1994 | CA2136837A1 1-azaadamantane derivatives as 5-ht agonists or antagonists |
| 02/02/1994 | EP0581677A1 Cycloalkylalkylamines which are sigma-receptor ligands, process for preparing them and their application in therapy |
| 02/02/1994 | EP0581187A1 Oxime derivatives |
| 02/02/1994 | EP0581166A1 Benzimidazoles, process for their preparation and their use as angiotensin-II antagonists |
| 02/02/1994 | EP0581106A1 Substituted aminothienopyridines, a process for their preparation and their use as medicaments |
| 02/02/1994 | EP0580627A1 Pharmaceutical composition for the treatment of gastritis |
| 02/02/1994 | EP0580616A1 New active compounds |
| 02/02/1994 | EP0580606A1 METHOD FOR DELIVERING DIRECT FEED MICROORGANISMS TO POULTRY $i(IN OVO) |
| 02/02/1994 | EP0294391B1 Process and composition for oral hygiene |
| 02/02/1994 | CN1081437A Anti-ulcer pyridyloxy derivatives, their preparation and uses |
| 02/02/1994 | CN1081366A Antibacterial antiplaque oral composition |
| 02/01/1994 | US5283268 Compounds for the treatment of inflammation and allergy |
| 01/26/1994 | EP0579958A1 A preventive or therapeutic medicine for pancreatitis |
| 01/26/1994 | EP0579602A1 Vasopressin and vasotocin derivates |
| 01/26/1994 | CN1081184A Erythromycin derivatives |
| 01/26/1994 | CN1023599C Process for preparing chloroaniline derivate |
| 01/26/1994 | CA2140916A1 Phosphonated arylethanolamine compounds with anti-hyperglycemic and/or anti-obesity activity |
| 01/25/1994 | US5281624 Neurological disorders associated with norepinephrine imbalance |
| 01/25/1994 | US5281606 N-substituted trifluoromethylphenyltetrahydropyridines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them |
| 01/25/1994 | US5281601 Muscarinic receptor antagonists |
| 01/25/1994 | US5281526 Method of purification of amylase by precipitation with a metal halide and 4-hydroxybenzic acid or a derivative thereof |
| 01/25/1994 | CA1326485C Thioformamide derivatives |
| 01/25/1994 | CA1326484C Substituted styrene derivatives |
| 01/25/1994 | CA1326454C Aqueous cathartic solution |
| 01/25/1994 | CA1326443C Hemorrhoidal, other compositions and methods of treatment |
| 01/23/1994 | CA2100927A1 Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them |
| 01/20/1994 | WO1994001554A1 Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions |
| 01/20/1994 | WO1994001547A2 A method for generation of antibodies to cell surface molecules |
| 01/20/1994 | WO1994001421A1 Benzothiazepine and benzoxazepine derivatives as cholecystokinin receptor antagonists |
| 01/20/1994 | WO1994001406A1 Contrast agents for mr diagnosis |
| 01/20/1994 | WO1994001112A1 Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders |
| 01/20/1994 | WO1994001111A1 Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders |
| 01/20/1994 | WO1994001099A1 Pharmaceutical composition having anti-alcohol, radioprotecting and anti-choleraic activity and stimulating energy metabolism, stomach mucous membrane acid-generation and secretion functions |
| 01/20/1994 | WO1994001095A2 Medicaments for the treatment of visceral pain and migraine |
| 01/20/1994 | CA2139735A1 Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions |
| 01/20/1994 | CA2139638A1 Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders |
| 01/20/1994 | CA2139636A1 Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders |
| 01/20/1994 | CA2139440A1 Medicaments for the treatment of visceral pain and migraine |
| 01/20/1994 | CA2139417A1 Benzothiazepine and benzoxazepine derivatives |
| 01/19/1994 | EP0579507A1 Isoxazole derivatives for the treatment of irritable bowel syndrome |
| 01/19/1994 | EP0579333A2 Antibacterial antiplaque oral composition |
| 01/19/1994 | EP0579155A2 Aqueous preparation of arulene sodium sulfonate |
| 01/19/1994 | EP0579066A2 N-substituted anilines |
| 01/19/1994 | EP0578965A1 Compositions and methods for treating gastrointestinal disorders |
| 01/19/1994 | EP0578847A1 Fused benzeneoxyacetic acid derivatives and their use as PG12 antagonists |